Abstract Details

Title De-novo Amantadine Treatment Delays Onset of Dyskinesias in Patients with Parkinson Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 188

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Maja Relja, MD (Zagreb University, Medical School of Zagreb) PRESENTER	No disclosure on file
Michael L. Reed, PhD (Vedanta Research)	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.

��ɫ����